Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2008
Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer
F Puglisi, G G Cardellino, D Crivellari, et al.
ESMO Open
|
January 4, 2025
Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy (GARIBALDI)
M Reni, M Milella, F Bergamo, et al.
ESMO Open
|
February 2, 2023
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey
M Reni, E Giommoni, F Bergamo, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
February 6, 2019
The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients
Debora Basile, Annamaria Parnofiello, Maria Grazia Vitale, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
October 10, 2024
Survival analysis of the metastatic cohort of Italian Association of Medical Oncology (AIOM) GARIBALDI survey
M Reni, E Giommoni, F Bergamo, et al.
Breast Cancer Research and Treatment
|
February 12, 2022
Systemic treatment in advanced phyllodes tumor of the breast: a multi-institutional European retrospective case-series analyses
E Palassini, O Mir, G Grignani, et al.
ESMO Open
|
June 20, 2025
Impact of age and sex on the efficacy and safety of ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy: a subgroup analysis of the ARMANI phase III trial
R Fazio, G Randon, F Bergamo, et al.
Cancers
|
July 2, 2021
TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase II INFINITY Study
Alessandra Raimondi, Federica Palermo, Michele Prisciandaro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 5, 2024
Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONO
A Raimondi, S Lonardi, S Murgioni, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2008
Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer
F Puglisi, G G Cardellino, D Crivellari, et al.
ESMO Open
|
January 4, 2025
Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy (GARIBALDI)
M Reni, M Milella, F Bergamo, et al.
ESMO Open
|
February 2, 2023
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey
M Reni, E Giommoni, F Bergamo, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
February 6, 2019
The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients
Debora Basile, Annamaria Parnofiello, Maria Grazia Vitale, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
October 10, 2024
Survival analysis of the metastatic cohort of Italian Association of Medical Oncology (AIOM) GARIBALDI survey
M Reni, E Giommoni, F Bergamo, et al.
Breast Cancer Research and Treatment
|
February 12, 2022
Systemic treatment in advanced phyllodes tumor of the breast: a multi-institutional European retrospective case-series analyses
E Palassini, O Mir, G Grignani, et al.
ESMO Open
|
June 20, 2025
Impact of age and sex on the efficacy and safety of ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy: a subgroup analysis of the ARMANI phase III trial
R Fazio, G Randon, F Bergamo, et al.
Cancers
|
July 2, 2021
TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase II INFINITY Study
Alessandra Raimondi, Federica Palermo, Michele Prisciandaro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 5, 2024
Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONO
A Raimondi, S Lonardi, S Murgioni, et al.
Page
of 2